Eli Lilly CEO explains supply chain of Covid-19 antibody drug

The U.S. Food and Drug Administration on Monday authorized emergency use of Eli Lilly’s experimental Covid-19 antibody treatment for non-hospitalized patients older than 65 or who have certain chronic medical conditions. Eli Lilly CEO David Ricks joins "Squawk Box" to discuss the plan to manufacture and distribute the medicine around the United States and the world.